<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
</head>
<body><p><span ><strong><u>ABNORMAL VAGINAL BLEEDING</u></strong></span></p><p style="margin-left:0in;text-align:justify;"><span >This refers&nbsp;to bleeding which deviates from the normal menstrual pattern&nbsp;(in&nbsp;terms&nbsp;of&nbsp;the&nbsp;amount, duration&nbsp;or&nbsp;interval).&nbsp;Abnormal&nbsp;menstrual patterns and bleeding are common in young adolescents and women within&nbsp;the&nbsp;ages&nbsp;of&nbsp;45-50&nbsp;years. No&nbsp;cause&nbsp;may&nbsp;be&nbsp;found&nbsp;on&nbsp;investigation&nbsp;in these&nbsp;age&nbsp;groups as&nbsp;it&nbsp;is&nbsp;mostly&nbsp;due&nbsp;to&nbsp;immaturity&nbsp;or&nbsp;ageing&nbsp;of&nbsp;the&nbsp;ovaries and its pituitary&nbsp;controls.</span> <span >Bleeding&nbsp;may&nbsp;be&nbsp;mild&nbsp;or&nbsp;severe&nbsp;and&nbsp;life&nbsp;threatening.</span> <span >In other age groups, the causes are multiple and may be associated with the identifiable disorders. Postmenopausal bleeding is said to occur when a woman who has stopped having menstruation for 6-12 or more months&nbsp;begins to&nbsp;bleed&nbsp;per&nbsp;vagina.&nbsp;0ccasionally&nbsp;bleeding&nbsp;from&nbsp;the&nbsp;rectum and urethra may be confused with genital tract bleeding.</span> <span >Treatment is directed at the cause found.</span></p><h3 style="margin-left:0in;">CAUSES</h3><p><strong>Pre-pubertal girls</strong></p><ul><li>Urethral mucosal&nbsp;prolapse</li><li>Coital lacerations due to rape and&nbsp;defilement</li><li>Trauma</li></ul><h3 style="margin-left:0in;">Young Adolescents</h3><ul><li>Dysfunctional uterine&nbsp;bleeding</li><li>Complications of&nbsp;pregnancy</li><li>Coital lacerations due to rape and&nbsp;defilement</li><li>Accidental traumatic lesions of vulva and&nbsp;vagina</li></ul><h3 style="margin-left:0in;">Women of Child Bearing Age</h3><ul><li>Complications&nbsp;of&nbsp;pregnancy,&nbsp;including&nbsp;ectopic&nbsp;pregnancy,&nbsp;abortion and&nbsp;choriocarcinoma</li><li>Coital&nbsp;lacerations</li><li>Use of hormonal methods of contraception or intrauterine contraceptive device&nbsp;(IUCD)</li><li>Cervical&nbsp;cancer</li><li>Fibroids</li><li>Dysfunctional&nbsp;bleeding</li></ul><h3 style="margin-left:0in;">Peri-menopausal Women</h3><ul><li>Dysfunctional uterine&nbsp;bleeding</li><li>All&nbsp;other&nbsp;causes&nbsp;listed for&nbsp;women&nbsp;of&nbsp;childbearing&nbsp;age&nbsp;also&nbsp;apply</li></ul><h3 style="margin-left:0in;">Post-menopausal Women</h3><ul><li>Pelvic&nbsp;cancers such&nbsp;as&nbsp;cervical cancer,&nbsp;endometrial&nbsp;cancer,&nbsp;vaginal or vulva cancer and ovarian&nbsp;tumours</li><li>Withdrawal from oestrogen&nbsp;therapy</li><li>Atrophic&nbsp;vaginitis</li><li>Endometritis</li><li>Coital&nbsp;tears</li><li>Urethral&nbsp;caruncle</li></ul><h3 style="margin-left:0in;">SYMPTOMS</h3><ul><li>Vaginal bleeding which deviates from normal menstrual pattern</li><li>May be associated lower abdominal pain or dysmenorrhoea</li><li>Symptoms of anaemia (dizziness, palpitations, easy fatigue&nbsp;etc.)</li></ul><h3 style="margin-left:0in;">SIGNS</h3><ul><li>Signs of anaemia (if heavy bleeding)</li><li>Other signs related to&nbsp;cause</li></ul><h3 style="margin-left:0in;">INVESTIGATIONS</h3><ul><li>FBC</li><li>Sickling test</li><li>Blood clotting screen e.g. Prothrombin time,&nbsp;INR</li><li>Pelvic ultrasound scan (to rule out pelvic&nbsp;lesions)</li><li>Urinalysis</li><li>Diagnostic Dilatation and Curettage (DD &amp; C) for women of child bearing age and postmenopausal women</li></ul><h3 style="margin-left:0in;">TREATMENT</h3><p><strong>Treatment objectives</strong></p><ul><li>To&nbsp;resuscitate patient where&nbsp;necessary</li><li>To&nbsp;find the cause of&nbsp;bleeding</li><li>To&nbsp;treat and stop the&nbsp;bleeding</li></ul><h3 style="margin-left:0in;">Non-pharmacological treatment</h3><ul><li>Vaginal coital tear - suturing in&nbsp;theatre</li><li>Inevitable or incomplete abortion - uterine evacuation</li><li>Surgery (myomectomy, hysterectomy,&nbsp;oophorectomy&nbsp;etc.)</li><li>Radiation therapy for cancers</li></ul><h3 style="margin-left:0in;">Pharmacological treatment</h3><ol><li><span ><strong>Dysfunctional&nbsp;uterine&nbsp;bleeding&nbsp;-&nbsp;mild&nbsp;bleeding</strong></span></li></ol><p style="margin-left:0in;"><span >1<sup>st</sup> Line Treatment Evidence Rating: [B]</span></p><ul><li>Norethisterone acetate, oral, 5 mg 8 hourly for 10-12 days (to stop bleeding)</li></ul><h3 style="margin-left:0in;">Then</h3><ul><li>5 mg 12 hourly (days 19 to 26 of cycle to prevent bleeding)</li></ul><p style="margin-left:0in;"><span >2<sup>nd</sup> Line Treatment Evidence Rating: [B]</span></p><ul><li>Mefenamic&nbsp;Acid, oral,&nbsp;500&nbsp;mg&nbsp;8&nbsp;hourly on&nbsp;days&nbsp;1&nbsp;to&nbsp;5&nbsp;of&nbsp;cycle (Especially&nbsp;if&nbsp;associated&nbsp;with&nbsp;dysmenorrhoea)</li></ul><ol><li><span ><strong>Life threatening&nbsp;bleeding&nbsp;</strong>1<sup>st</sup> Line Treatment Evidence Rating:&nbsp;[A]</span></li></ol><ul><li>IV fluids and blood transfusion as&nbsp;required</li></ul><p style="margin-left:0in;"><strong>And</strong></p><p style="margin-left:0in;"><span >Evidence Rating: [A]</span></p><ul><li>Tranexamic&nbsp;Acid,&nbsp;oral&nbsp;or IV,&nbsp;1&nbsp;g&nbsp;6-8&nbsp;hourly&nbsp;for&nbsp;4-7&nbsp;days</li></ul><p style="margin-left:0in;"><span >2<sup>nd</sup> Line Treatment Evidence Rating: [B]</span></p><ul><li>Mefenamic&nbsp;Acid, slow&nbsp;IV&nbsp;injection,&nbsp;500&nbsp;mg&nbsp;8&nbsp;hourly(days&nbsp;1&nbsp;to&nbsp;5&nbsp;of cycle)</li></ul><ol><li><span >For recurrent or protracted abnormal&nbsp;bleeding</span></li></ol><p style="margin-left:0in;"><span >1<sup>st</sup> Line Treatment Evidence Rating [A]</span></p><p style="margin-left:0in;"><span >Low dose oral contraceptive pill daily for 3-6 cycles or longer</span></p><ul><li>Ethinylestradiol +&nbsp;levonorgestrel</li></ul><h3 style="margin-left:0in;">Or</h3><ul><li>Ethinylestradiol +&nbsp;norethisterone</li></ul><p style="margin-left:0in;"><span >2<sup>nd</sup> Line Treatment Evidence Rating: [C]</span></p><ul><li>Conjugated&nbsp;oestrogen,&nbsp;oral,&nbsp;1.25-2.5&nbsp;mg&nbsp;daily&nbsp;for&nbsp;10-12&nbsp;days</li></ul><h3 style="margin-left:0in;">And</h3><p style="margin-left:0in;"><span >Evidence Rating: [A]</span></p><ul><li>Norethisterone,&nbsp;oral,5-10&nbsp;mg&nbsp;8&nbsp;hourly&nbsp;for&nbsp;21&nbsp;days&nbsp;(days&nbsp;5-25)</li></ul><h3 style="margin-left:0in;">Or</h3><p style="margin-left:0in;"><span >Evidence Rating: [B]</span></p><ul><li>Medroxyprogesterone acetate, oral, 5-10 mg daily for 5-10 days (days 19 to 26 of&nbsp;cycle)</li></ul><p><strong>REFERRAL CRITERIA</strong></p><p style="margin-left:0in;text-align:justify;"><span >Refer all women with heavy menstrual bleeding and/or abnormal vaginal bleeding not responding to therapy to a gynaecologist for comprehensive assessment and management.</span></p><p>&nbsp;</p><p>&nbsp;</p>
</body>
</html>
